Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ALT

Altimmune (ALT)

Altimmune Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALT
DateTimeSourceHeadlineSymbolCompany
06/30/20215:46AMTipRanksAltimmune Not Immune to Poor Results; Drops AdCOVID Vaccine programNASDAQ:ALTAltimmune Inc
06/29/20214:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALTAltimmune Inc
06/29/20214:01PMGlobeNewswire Inc.Altimmune Announces Update on AdCOVID™ Phase 1 Clinical TrialNASDAQ:ALTAltimmune Inc
06/16/20217:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALTAltimmune Inc
06/16/20217:00AMGlobeNewswire Inc.Altimmune Announces Positive Interim Data from ALT-801 Phase 1 Trial in Overweight and Obese VolunteersNASDAQ:ALTAltimmune Inc
06/02/20217:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTAltimmune Inc
05/27/20217:00AMGlobeNewswire Inc.Altimmune to Present at the 2021 Jefferies Virtual Healthcare ConferenceNASDAQ:ALTAltimmune Inc
05/26/20217:00AMGlobeNewswire Inc.Altimmune Demonstrates Strong Neutralization of South African Variant in Preclinical Study of Intranasal AdCOVID™NASDAQ:ALTAltimmune Inc
05/17/20217:13AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALTAltimmune Inc
05/17/20217:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALTAltimmune Inc
05/17/20217:00AMGlobeNewswire Inc.Altimmune Announces First Quarter 2021 Financial Results and Provides a Corporate UpdateNASDAQ:ALTAltimmune Inc
05/11/20217:00AMGlobeNewswire Inc.Altimmune to Announce First Quarter 2021 Financial Results on May 17, 2021NASDAQ:ALTAltimmune Inc
05/10/20217:00AMGlobeNewswire Inc.Altimmune Announces New Preclinical Data for AdCOVID™ Demonstrating Sterilizing Immunity After a Single Intranasal DoseNASDAQ:ALTAltimmune Inc
05/04/20217:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTAltimmune Inc
04/29/20217:00AMGlobeNewswire Inc.Altimmune to Present at Upcoming Scientific ConferencesNASDAQ:ALTAltimmune Inc
04/01/20217:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALTAltimmune Inc
04/01/20217:00AMGlobeNewswire Inc.Altimmune Reports Data from its Phase 1b Clinical Trial of NasoShield™NASDAQ:ALTAltimmune Inc
03/31/20217:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTAltimmune Inc
03/22/20217:00AMGlobeNewswire Inc.Altimmune Partners with Summit Biosciences to Produce a Multidose Nasal Spray Presentation of its AdCOVID™ Vaccine Candidat...NASDAQ:ALTAltimmune Inc
03/15/20217:00AMGlobeNewswire Inc.AdCOVID™, Altimmune’s Single Dose, Intranasal COVID-19 Vaccine Candidate, Prevents SARS-CoV-2-induced Disease and Blocks ...NASDAQ:ALTAltimmune Inc
03/14/20215:18AMTipRanksAltimmune Extends Lonza Partnership To Support Production Of AdCOVIDNASDAQ:ALTAltimmune Inc
03/12/20216:44AMDow Jones NewsAltimmune Expands Manufacturing Agreement for Covid-19 Vaccine CandidateNASDAQ:ALTAltimmune Inc
03/12/20211:00AMGlobeNewswire Inc.Altimmune Expands AdCOVID™ Manufacturing Collaboration with LonzaNASDAQ:ALTAltimmune Inc
03/08/20214:01PMGlobeNewswire Inc.Altimmune to Present at Upcoming ConferencesNASDAQ:ALTAltimmune Inc
03/01/20214:09PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ALTAltimmune Inc
03/01/20214:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTAltimmune Inc
02/25/20214:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALTAltimmune Inc
02/25/20218:19AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ALTAltimmune Inc
02/25/20217:12AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ALTAltimmune Inc
02/25/20217:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALTAltimmune Inc
 Showing the most relevant articles for your search:NASDAQ:ALT